BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 22878836)

  • 21. Diagnostic Accuracy of Preoperative Imaging for Differentiation of Branch Duct Versus Mixed Duct Intraductal Papillary Mucinous Neoplasms.
    Ugbarugba EE; Grieco C; Hart PA; Li F; Sklaw B; Cronley K; Oza VM; Swanson BJ; Walker JP; El-Dika S; Conwell DL; Krishna SG
    Pancreas; 2018; 47(5):556-560. PubMed ID: 29683969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
    Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
    JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features.
    Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y
    Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic Fistula Extending into the Thigh Caused by the Rupture of an Intraductal Papillary Mucinous Adenoma of the Pancreas.
    Shimizu Y; Imaizumi H; Yamauchi H; Okuwaki K; Miyazawa S; Iwai T; Takezawa M; Kida M; Suzuki E; Saegusa M; Koizumi W
    Intern Med; 2017; 56(3):307-313. PubMed ID: 28154275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasia diagnosed by EUS.
    Ringold DA; Shroff P; Sikka SK; Ylagan L; Jonnalagadda S; Early DS; Edmundowicz SA; Azar R
    Gastrointest Endosc; 2009 Sep; 70(3):488-94. PubMed ID: 19555941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
    Raman SP; Kawamoto S; Blackford A; Hruban RH; Lennon AM; Wolfgang CL; Rezaee N; Edil B; Fishman EK
    AJR Am J Roentgenol; 2013 Mar; 200(3):563-9. PubMed ID: 23436845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy.
    Goong HJ; Moon JH; Choi HJ; Lee YN; Choi MH; Kim HK; Lee TH; Cha SW
    Gut Liver; 2015 Sep; 9(5):685-8. PubMed ID: 26087782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Kobayashi N; Sugimori K; Shimamura T; Hosono K; Watanabe S; Kato S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A; Kubota K
    Pancreatology; 2012; 12(2):141-5. PubMed ID: 22487524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous Neoplasm.
    Kashiwagi K; Seino T; Fukuhara S; Minami K; Horibe M; Iwasaki E; Takaishi H; Itoh K; Sugino Y; Inoue N; Iwao Y; Kanai T
    Pancreas; 2018 Oct; 47(9):1087-1092. PubMed ID: 30028443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm.
    Lee KH; Lee SJ; Lee JK; Ryu JK; Kim EY; Kim TH; Moon JH; Lee WJ; Cho YK; Kim JJ
    Pancreas; 2014 Nov; 43(8):1306-11. PubMed ID: 25036913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
    Smith LA; McKay CJ
    Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia.
    Emerson RE; Randolph ML; Cramer HM
    Diagn Cytopathol; 2006 Jul; 34(7):457-62. PubMed ID: 16783773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012.
    Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Aso T; Miyasaka Y; Ueda J; Takahata S; Osoegawa T; Igarashi H; Ito T; Ushijima Y; Ookubo F; Oda Y; Mizumoto K; Tanaka M
    World J Surg; 2014 Nov; 38(11):2994-3001. PubMed ID: 25037612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.
    Schellhaas B; Vitali F; Wildner D; Görtz RS; Pfeifer L; Konturek PC; Neurath MF; Strobel D
    Med Sci Monit; 2017 Mar; 23():1483-1492. PubMed ID: 28348359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
    Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
    World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI.
    Choi SY; Kim JH; Yu MH; Eun HW; Lee HK; Han JK
    Abdom Radiol (NY); 2017 May; 42(5):1449-1458. PubMed ID: 28144718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.